Age, Biography and Wiki
Bart Deplancke was born on 21 August, 1975. Discover Bart Deplancke's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 48 years old?
Popular As |
N/A |
Occupation |
N/A |
Age |
49 years old |
Zodiac Sign |
Leo |
Born |
21 August, 1975 |
Birthday |
21 August |
Birthplace |
N/A |
Nationality |
|
We recommend you to check the complete list of Famous People born on 21 August.
He is a member of famous with the age 49 years old group.
Bart Deplancke Height, Weight & Measurements
At 49 years old, Bart Deplancke height not available right now. We will update Bart Deplancke's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
Family |
Parents |
Not Available |
Wife |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Bart Deplancke Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Bart Deplancke worth at the age of 49 years old? Bart Deplancke’s income source is mostly from being a successful . He is from . We have estimated
Bart Deplancke's net worth
, money, salary, income, and assets.
Net Worth in 2023 |
$1 Million - $5 Million |
Salary in 2023 |
Under Review |
Net Worth in 2022 |
Pending |
Salary in 2022 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
|
Bart Deplancke Social Network
Instagram |
|
Linkedin |
|
Twitter |
|
Facebook |
|
Wikipedia |
|
Imdb |
|
Timeline
In 2020, he co-founded Alithea Genomics, a company specializing in making high-throughput transcriptomics highly affordable for academic projects, biobank functionalization, and drug screening platforms.
In 2017, he was elected to the National Research Council of the Swiss National Science Foundation.
In 2011, Deplancke co-founded Genohm, a company delivering software (big data management) products and services for pharmaceutical and R&D laboratories, which was acquired by Agilent in May 2018.
In 2005, Deplancke received the Peter Reeds Young Investigator Award from the American Society for Nutritional Sciences for his work on the impact of genetic factors in response to bacterial infections.
Deplancke studied biochemical engineering at Ghent University and graduated with a Master of Science in 1998. In 2002, he obtained a PhD in immunobiology from the University of Illinois at Urbana-Champaign for his studies on intestinal host-microbe interactions and innate immunity. He then pursued postdoctoral studies in the laboratories of Marc Vidal (Harvard Medical School) and Marian Walhout (University of Massachusetts), where he developed a high-throughput protein-DNA interaction screening approach and worked on elucidating metazoan genetic regulatory networks. In 2007, he established his own lab at École Polytechnique Fédérale de Lausanne, where he was successively promoted to associate professor in 2014, and to full professor in 2020. He is currently vice-dean for innovation there. He is a cofounder of the Junior European Drosophila Investigators (JEDI) scientific network. Since 2013, Deplancke is a group leader at the Swiss Institute of Bioinformatics.
Bart Deplancke (born 21 August 1975) is a Belgian bio-engineer and researcher. He is a full professor at École Polytechnique Fédérale de Lausanne, where he leads the laboratory of systems biology and genetics.